Abstract
ObjectiveTo investigate the cardiovascular effectiveness of sodium glucose cotransporter 2 (SGLT2) inhibitors in routine clinical practice.DesignCohort study using data from nationwide registers and an active-comparator new-user design.SettingDenmark, Norway, and Sweden,...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
